New, Expanded Offerings from McKesson Specialty Health help community oncology practices overcome challenges to better care for patientsSeptember 19, 2011 |
|
|||
|
McKesson Specialty Health unveils its newly expanded and enhanced Onmark Select Program providing oncologists with flexibility, choice and value The Woodlands, Texas (Sept. 19, 2011) - In today’s dynamic healthcare environment, community-based oncologists face increasing challenges. To empower community-based oncology practices to remain independent, grow and deliver high-quality care to patients in the midst of these challenges, McKesson Specialty Health unveiled today its Onmark Select Program. “Community-based cancer care is a precious resource. Between reimbursement pressures, rising costs, increasing competition and the uncertainty of healthcare reform, community oncology practices face a challenging environment,” said Bruce Broussard, CEO, McKesson Specialty Health. “McKesson Specialty Health’s Onmark Select Program provides flexible solutions to help practices perform under pressure, allowing each practice to engage with our broad array of proven clinical, technology and business support services in its own way. Onmark Select helps practices meet today’s challenges head on, allowing them to remain independent, grow, and advance patient care.” The Onmark Select Program, delivered through McKesson Specialty Health’s Solutions for Oncology, empowers vibrant and sustainable independent community-based oncology practices to advance the science, technology and quality of care through proven, customizable services. Engaging with McKesson Specialty Health through the Onmark Select Program allows practices to thrive in today’s challenging environment, achieve their business and clinical goals, and ultimately better the health of the practices and the patients they serve. Practices participating in the Onmark Select Program benefit from McKesson Specialty Health’s expertise and leadership in advanced technology, business and operational support and clinical support. Advanced Technology
Business and Operational Leadership
Clinical Leadership
Flexible Solutions to Strengthen Community Practices “Through a flexible range of services, the Onmark Select Program helps practices gain purchasing efficiencies, grow patient volumes, optimize revenue and enhance productivity so community oncologists can focus on what they do best: provide advanced, high-quality care to patients fighting cancer,” said Mark Walchirk, President, McKesson Specialty Health. “Our innovative clinical and business capabilities and our advanced, integrated technology strengthen community-based practices. Through our unmatched breadth and depth of services and expertise, we offer community oncology practices a competitive advantage in challenging times.” For more details on The Onmark Select Program and its offerings, visit About McKesson Specialty HealthMcKesson Specialty Health, a division of McKesson Corporation, empowers the community patient care delivery system to advance the science, technology and quality of care. Through innovative clinical, research, business and operational solutions, facilitated by integrated technology systems, we improve the financial health of our customers and help them provide quality care for patients. For more information, visit www.mckessonspecialtyhealth.com. About McKessonMcKesson Corporation, currently ranked 15th on the FORTUNE 500, is a healthcare services and information technology company dedicated to making the business of healthcare run better. We partner with payers, hospitals, physician offices, pharmacies, pharmaceutical companies and others across the spectrum of care to build healthier organizations that deliver better care to patients in every setting. McKesson helps its customers improve their financial, operational, and clinical performance with solutions that include pharmaceutical and medical-surgical supply management, healthcare information technology, and business and clinical services. For more information, visit www.mckesson.com. PR Contact
Claire Crye |
||||